In conclusion, these findings shed light on two polymorphisms (rs3784619 and rs11637235) in the DUT gene associated with a higher risk of CIN III and CSCC that could be used as biomarkers. The gene discussed is DUT; the disease is uterine cervix carcinoma in situ.